GWMIA
XENE icon

Global Wealth Management Investment Advisory’s Xenon Pharmaceuticals XENE Stock Holding History

Global Wealth Management Investment Advisory’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-20
Closed – – 507
2021
Q3 		$0 Hold
20
– – ﹤0.01% 494
2021
Q2 		$0 Hold
20
– – ﹤0.01% 501
2021
Q1 		$0 Hold
20
– – ﹤0.01% 529
2020
Q4 		$0 Hold
20
– – ﹤0.01% 517
2020
Q3 		$0 Hold
20
– – ﹤0.01% 647
2020
Q2 		$0 Buy
+20
New +$255 ﹤0.01% 696

Other funds holding XENE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Global Wealth Management Investment Advisory's XENE Position: Q4 2021 in Review

Global Wealth Management Investment Advisory sold out of Xenon Pharmaceuticals (XENE) in Q4 2021, closing a stake of 20 shares.

Global Wealth Management Investment Advisory first reported a position in XENE in Q2 2020 and held it in 6 quarters. The position peaked at $0 in Q3 2021. 130 funds tracked by Wall St. Rank hold XENE as of Q4 2021.

  • Global Wealth Management Investment Advisory reported no remaining Xenon Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Global Wealth Management Investment Advisory sold 20 Xenon Pharmaceuticals shares in Q4 2021.
  • Global Wealth Management Investment Advisory first reported a position in Xenon Pharmaceuticals in Q2 2020 and held it in 6 quarters.
  • Global Wealth Management Investment Advisory's Xenon Pharmaceuticals position peaked at $0 in Q3 2021.
  • 130 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q4 2021.

Based on Global Wealth Management Investment Advisory's 13F filing for Q4 2021, filed 15 Feb 2022.